Condition

PCOS

ClinicalTrials.gov condition label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 25 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials25
Recruiting1
Common interventions25
Lead sponsors shown15
Advertisement

Clinical trials

25 shown
Liraglutide Treatment in Obese Infertile PCOS WomenNCT06742710 · 2025-05-22
RECRUITING
Effects of Sprint Interval Training Versus Arabic Exercises BMINCT06461585 · 2023-12-10
UNKNOWN
The Living With a Long-Term Condition StudyNCT06072287 · 2023-06-28
UNKNOWN
Ketogenic Diet in PCOS With Obesity and Insulin ResistanceNCT04801173 · 2021-03-02
COMPLETED
Glucose Metabolism and Live Birth Outcomes in PCOSNCT04364087 · 2020-06-01
COMPLETED
Effects of Acupuncture on Body Mass Index in Overweight and Obese Women With Polycystic Ovary Syndrome (PCOS )NCT04193371 · 2019-12-06
COMPLETED
The Effects of Semaglutide on Taste, Tongue Tissue Transcriptome, Gastric Emptying and Central Neural Response in Women With PCOS and ObesityNCT04263415 · 2019-11-02
COMPLETED
Treating PCOS With Semaglutide vs Active Lifestyle InterventionNCT03919929 · 2019-05-03
COMPLETED
A Treatment Legacy Effect of Metformin in Obese Women With PCOSNCT04566718 · 2019-03-25
COMPLETED
The Gut Microbiome in Women With Polycystic Ovary SyndromeNCT03642600 · 2019-02-28
COMPLETED
In Vitro Fertilization Impact on Metabolic ParametersNCT03426228 · 2018-02-15
COMPLETED
Comparing the Effects of Oral Contraceptive Pills Versus MetforminNCT03229057 · 2018-01-15
COMPLETED
Effect of Dietary Modifacation on Microbiota in Overweight and Obese Polycystic Ovary Syndrome PatientsNCT03325023 · 2017-05-20
UNKNOWN
L-carnitine and Metformin in Obese PCOS Women.NCT03108963 · 2017-01-01
COMPLETED
Sitagliptin Improved Beta Cell Function and Prevented a Conversion Rate to Impaired Glucose Tolerance and Type 2 Diabetes in Metformin Intolerant Obese Women With Polycystic Ovary SyndromeNCT03122041 · 2016-08-01
COMPLETED
Non-alcoholic Fatty Liver Disease in Women With Polycystic Ovary SyndromeNCT05843955 · 2015-09-01
COMPLETED
Ultrasonographic Evaluation of Anovulatory Disorders in Lean and Overweight WomenNCT03306849 · 2015-08-01
COMPLETED
Short Term Weight Loss With Liraglutide and Metformin in Infertile Obese PCOS PatientsNCT03034941 · 2014-04-01
COMPLETED
PDE-4 Inhibitor Roflumilast and GLP-1 Agonist Liraglutide in Polycystic Ovary SyndromeNCT02187250 · 2014-03-01
COMPLETED
Liraglutide as Add on Therapy on Metformin in Women With Polycystic Ovary SyndromeNCT02483299 · 2014-01-01
COMPLETED
PDE-4 Inhibitor Roflumilast and Polycystic Ovary SyndromeNCT02037672 · 2013-09-01
COMPLETED
Polycystic Ovary Syndrome and Liraglutide as Add-on Therapy on MetforminNCT01911468 · 2011-11-01
COMPLETED
Polycystic Ovary Syndrome and LiraglutideNCT01899430 · 2011-11-01
COMPLETED
Cavitation Ultrasound in Treatment of Patients With PCOSNCT01622257 · 2011-06-01
COMPLETED
Insulin and Polycystic Ovary SyndromeNCT00683774 · 2005-11-01
COMPLETED

Common interventions

Trial status mix

COMPLETED21
UNKNOWN3
RECRUITING1

Phase mix

PHASE411
NA4
PHASE23
PHASE32
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.